REG - OptiBiotix Health - Holding(s) in Company <Origin Href="QuoteRef">OPTIO.L</Origin>
RNS Number : 5316AOptiBiotix Health PLC24 March 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:iiOptibiotix Health plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
change in percentage of voting rights arising upon a new issue of shares by the issuer
3. Full name of person(s) subject to the
notification obligation:iiiFinance Yorkshire Seedcorn Fund (FYSCF)
4. Full name of shareholder(s)
(if different from 3.):iv5. Date of the transaction and date on
which the threshold is crossed or
reached:v6 March 2017
6. Date on which issuer notified:
10 March 2017
7. Threshold(s) that is/are crossed or
reached: vi, vii14%
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares
if possible using
the ISIN CODESituation previous
to the triggering
transactionResulting situation after the triggering transaction
Number
of
SharesNumber
of
Voting
RightsNumber
of sharesNumber of voting
rights% of voting rights
Direct
Direct xi
Indirecti
Direct
Indirect
GB00BP0RTP38
11,999,314
11,999,314
10,499,314
10,499,314
nil
13.40
Nil
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrumentExpiration
date xiiiExercise/
Conversion Period xivNumber of voting
rights that may be
acquired if the
instrument is
exercised/ converted.% of voting
rightsNone
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrumentExercise price
Expiration date xvii
Exercise/
Conversion period xviiiNumber of voting rights instrument refers to
% of voting rights xix, xx
None
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
10,499,314
13.40%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxiProxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14. Contact name:
Enterprise Ventures Limited
15. Contact telephone number:
01772 270 570
This information is provided by RNSThe company news service from the London Stock ExchangeENDHOLPGUWWWUPMGMC
Recent news on OptiBiotix Health
See all newsRCS - OptiBiotix Health - Manufacturing agreement with KAG Industries
AnnouncementREG - OptiBiotix Health - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 28/03/2024
AnnouncementREG - OptiBiotix Health - Placing, Subscription and Director Dealing
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
Announcement